The Multifaceted Future of Pharma – Betting on Biopharma and Better Bioprocessing
"Collaboration is key to driving innovation in biopharma," according to Seokjin Chang, Senior Director of Market Intelligence. He adds, “The expertise of drug developers coupled with the capabilities of CDMOs can accelerate the development of novel therapies and bring them to patients faster.”
For insights on the importance of strong partnerships to advance new treatment options and the growing potential of drug conjugates, check out this Medicine Maker roundtable.
"Collaboration is key to driving innovation in biopharma," according to Seokjin Chang, Senior Director of Market Intelligence. He adds, “The expertise of drug developers coupled with the capabilities of CDMOs can accelerate the development of novel therapies and bring them to patients faster.”
For insights on the importance of strong partnerships to advance new treatment options and the growing potential of drug conjugates, check out this Medicine Maker roundtable.
- CDO
- CGMP
- ADC
- Bio Campus
- IR
- CMO
Share article